Optain transforms preventive health with AI-enabled software and hardware that deliver real-time, non-invasive detection of eye and systemic conditions. Its portable robotic retinal camera, AI, and teleophthalmology service give clinicians an affordable point-of-care tool to close care gaps, reduce avoidable costs, and improve patient outcomes.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/11/25 | $26,000,000 | Series A |
Informed Ventures Insight Partners  Lumio Capital Meridian Ventures Uniquest | undisclosed |
